PIERRE FABRE LIMITED: UK Public Sector Contracts Won & Awards
Large organisation·London·Greater London·Main market: Pharmaceutical products
Official UK PPONPRHQ-6453-ZCGD
Procedures with an award1515 award recordsPublic authorities5named on published awardsAttributable award value£5.2mnet · on 9 of 15 award records · single-supplier, no ceilingsLast 12 months3awards · 6 in the prior 24 months · last 27 Aug 2026Contracts ending ≤18 months1end date published on 3 of 15 awardsDelivery regions12most often Northern Ireland
Where they win
15 lot-level observations (5 awarded lots, 33%, plus 10 envelope awards without lot links; pending awards included) · top CPV classes
3360 Pharmaceutical products10 observations · 67% · 5 lots + 5 envelope3300 Medical equipments, pharmaceuticals and personal care products5 observations · 33% · envelope awardsAttributable award value£5.2mSum of published VAT-exclusive values on 9 of 15 award records — only awards to this supplier alone, framework / DPS ceilings excluded; the award’s own value, else its contract’s; the five largest make 83%. Not turnover. Largest rows below.
Typical attributable award£500k medianrobust · n=9
| Largest published awards | Authority | Awarded | Term | Published value |
|---|---|---|---|---|
| ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack | Belfast Health & Social Care Trust | 9 Jun 2025 | 2 yrs | £1,200,000 ≈ £600k/yr |
| Procurement of BINIMETINIB 15 mg Film Coated Tablets 84 Tablet Pack | Belfast Health & Social Care Trust | — | — | £930,000 † |
| ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack | Belfast Health & Social Care Trust | — | — | £900,000 † |
| Procurement of ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack | Belfast Health & Social Care Trust | — | — | £800,000 † |
| Procurement of Binimetinib from Pierre Fabre Limited | Belfast Health & Social Care Trust | — | — | £500,000 † |
Where they deliver
ITL1 delivery regions on the notice · 15 of 15 awarded procedures publish one · a procedure with several regions counts in each
Northern Ireland9 procedures · 60%
Nationwide (UK)4 procedures · 27%
North East England1 procedures · 7%
North West England1 procedures · 7%
Yorkshire and the Humber1 procedures · 7%
East Midlands1 procedures · 7%
West Midlands1 procedures · 7%
East of England1 procedures · 7%
Bidding record
Procurement Act 2023 award notices name every bidder · 2 notices name this supplier since 26 Feb 2026 · observed bids, not an estimate
Contract contests0 won · 0 lostFewer than three decided contests — no rate is claimed.
Framework / DPS places1 of 2Admissions to a panel or dynamic market are counted apart: nearly every compliant bidder is appointed, so they say nothing about winning work.
Authorities bid for1
| Notice | Authority | Outcome | Bidders | Published |
|---|---|---|---|---|
| NHS National Generic Pharmaceuticals - Wave 16a | NHS England | appointed | 125 | 1 Sept 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | NHS England | not appointed | 118 | 26 Feb 2026 |
Source: bids.details[].tenderers on Procurement Act 2023 notices (from 2025). PCR 2015 notices name no bidders, so earlier contests are invisible here. Latest ten notices shown.
Who they sell to
Authorities named on this supplier’s published awards · ranked by distinct procedures · award records explode on framework and DPS panels
Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
- NHS & health 73% (11 awards)
- Central government 27% (4 awards)
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| Belfast Health & Social Care Trust | 7 | 46.7% | 7 | 17 Apr 2026 |
| NHS England | 4 | 26.7% | 4 | 27 Aug 2026 |
| Northern Health and Social Care Trust | 2 | 13.3% | 2 | 17 Aug 2026 |
| The NHS Commissioning Board (operating under the name of NHS England) | 1 | 6.7% | 1 | 14 Jan 2022 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 1 | 6.7% | 1 | 22 Jun 2021 |
Share = of the 15 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts ending
Published end dates only · 3 of 15 awards carry one · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack | 30 Jun 2027 | £1,200,000 |
Recent awards
Latest 15 of 15 award records naming this supplier
| Award / procedure | Authority | Awarded | Award value |
|---|---|---|---|
| Lot 2 - CM/PHG/24/2714/02 Hospital Only products DLN & DNW regions | NHS England | 27 Aug 2026 | £393,331,872 |
| ENCORAFENIB (BRAFTOVI) 75 mg Capsules | Northern Health and Social Care Trust | 17 Aug 2026 | £180,000 |
| BINIMETINIB 45MG 28PK | Belfast Health & Social Care Trust | 17 Apr 2026 | £420,000 |
| ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack | Belfast Health & Social Care Trust | 9 Jun 2025 | £1,200,000 |
| Wave 15b - Hospital Only DCE & DSW regions | NHS England | Not published | Not published |
| NERATINIB 40 mg Tablets 180 Tablet Pack | Belfast Health & Social Care Trust | Not published | Not published |
| Wave 15a - Hospital Only Products (DNW & DLN regions) | NHS England | Not published | Not published |
| Contract for ENCORAFENIB (BRAFTOVI) 75mg Capsules | Northern Health and Social Care Trust | Not published | Not published |
| ENCORAFENIB 75 mg Hard Capsules 42 Capsule Pack | Belfast Health & Social Care Trust | Not published | Not published |
| Lot 1 - CM/PHG/22/5657/02 Hospital Only Products: DLN & DNW: | NHS England | Not published | Not published |
Data coverage & method
- Source: Find a Tender OCDS award and contract releases. An award record is one award × this supplier; a procedure can carry many (panels, call-offs).
- Market observations are awarded lots, or one envelope award when the notice publishes no lot links. Region = delivery ITL1 on the notice, not the supplier’s registered address.
- Authority type: official OCDS UK contracting-authority type when the notice publishes one; otherwise a Tenderline name/id class; otherwise “not classified”. Purchasing hubs with no published type stay unclassified.
- Published value attributable to this supplier alone: £5.2m across single-supplier awards, framework / DPS ceilings excluded. Coverage is partial and the figure is not turnover, so it is not shown as a headline.
- Contract end dates: published on 3 of 15 awards; 1 end within 18 months.
- Never shown: contact details, reliability or payment scores, affiliations, predicted wins.
Identifiers consolidated into this page (5 historical Find a Tender publication identifiers)
Official notices referenced this supplier under these publication identifiers. Alias URLs are not separate pages.
Canonical page id: GB-PPON:PRHQ-6453-ZCGD